TechForce advances PUR-E Phase 2 deployment at SAPU Bio facility
TechForce Robotics advanced a Phase 2 deployment of its PUR-E pharmaceutical automation system at SAPU Bio’s OEB-5 sterile injectable cGMP facility.
Evidence notes
- Phase 2 deployment places PUR-E automation inside SAPU Bio cGMP operations.
- The deployment targets sterile injectable pharmaceutical manufacturing workflows.
Company context
TechForce Robotics develops robotics and automation systems for industrial, semiconductor, laboratory and pharmaceutical environments. Its June 2026 Jiun Jiang agreement adds supply and development scope across AI infrastructure, machine vision, precision motion and materials handling.